Market Cap (In INR)
20.26 Billion
Revenue (In INR)
7.09 Billion
Net Income (In INR)
498.26 Million
Avg. Volume
148.05 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 113.3-398.0
- PE
- 30.61
- EPS
- 7.82
- Beta Value
- 1.289
- ISIN
- INE812G01025
- CUSIP
- Y806AK131
- CIK
- -
- Shares
- 84652000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Mr. Ramesh Babu Potluri
- Employee Count
- -
- Website
- https://www.smspharma.com
- Ipo Date
- 2007-02-28
- Details
- SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.
More Stocks
-
002255
-
QGLDFQ-Gold Resources Ltd.
QGLDF
-
ANKOFAngkor Resources Corp.
ANKOF
-
CTP2Comcast Corporation
CTP2
-
NOKBFNokia Oyj
NOKBF
-
FCAPFirst Capital, Inc.
FCAP
-
INL
-
SOLBSolvay SA
SOLB